{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/59660376"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "The law would apply to drugs costing $10,000 or more for a course of treatment, and companies would have to report information such as production costs, sales and marketing costs, and financial assistance provided through prescription assistance programs." ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "pharmacertify.com" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/417205180"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/59660376"] } } }
